Antibody response toPseudomonas aeruginosain cystic fibrosis patients: A marker of therapeutic success?-A 30-year Cohort study of survival in Danish CF patients after onset of chronicP. aeruginosalung infection

2004 ◽  
Vol 37 (5) ◽  
pp. 427-432 ◽  
Author(s):  
Helle Krogh Johansen ◽  
Lena Nørregaard ◽  
Peter C. Gøtzsche ◽  
Tacjana Pressler ◽  
Christian Koch ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Cohort Study ◽  
Antibody Response ◽  
Therapeutic Success

Bacteria of the genus Dyella can chronically colonise the airways of patients with cystic fibrosis and elicit a pronounced antibody response

2013 ◽  
Vol 303 (5) ◽  
pp. 267-269 ◽  
Author(s):  
Liv M. Duus ◽  
Niels Høiby ◽  
Mikala Wang ◽  
Oluf Schiøtz ◽  
Niels Nørskov-Lauritsen
Keyword(s):  
Cystic Fibrosis ◽  
Antibody Response

scholarly journals A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of age

2010 ◽  
Vol 110 (4) ◽  
pp. 388-395 ◽  
Author(s):  
Todd A. Jusko ◽  
Anneclaire J. De Roos ◽  
Stephen M. Schwartz ◽  
B. Paige Lawrence ◽  
Lubica Palkovicova ◽  
...  
Keyword(s):  
Cohort Study ◽  
Antibody Response ◽  
Polychlorinated Biphenyl ◽  
Post Vaccination ◽  
Pcb Exposure

Longitudinal Trends in Real-World Outcomes after Initiation of Ivacaftor. A Cohort Study from the Cystic Fibrosis Registry of Ireland

2019 ◽  
Vol 16 (2) ◽  
pp. 209-216 ◽  
Author(s):  
Laura Kirwan ◽  
Godfrey Fletcher ◽  
Mary Harrington ◽  
Paulina Jeleniewska ◽  
Shijun Zhou ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Cohort Study ◽  
Real World

scholarly journals Predicting the risk of atherosclerosis in patients with cystic fibrosis – rationale and design of a prospective cohort study

2015 ◽  
Vol 84 (2) ◽  
pp. 126-128
Author(s):  
Edyta Mądry ◽  
Jan Nowak ◽  
Andrzej Wykrętowicz ◽  
Ewa Wenska-Chyży ◽  
Anna Miśkiewicz-Chotnicka ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Cohort Study ◽  
Heart Disease ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Metabolic Diseases ◽  
Chronic Obstructive ◽  
Science Center ◽  
Obstructive Pulmonary Disease ◽  
Endogenous Factors

The project “Risk of atherosclerosis in cystic fibrosis in relation to the exogenous and endogenous factors that influence the course of the disease” ranked first in the OPUS2 Competition, as announced in May 2012 by the Polish National Science Center. The total value of the grant is 198,580 PLN (ca. 50,000 EUR). The grant was awarded jointly to the Department of Pediatric Gastroenterology and Metabolic Diseases and to the Department of Cardiac Intensive Care at Poznan University of Medical Sciences, Poland. The project will be focused on conducting a prospective cohort study in patients with cystic fibrosis (CF) and healthy controls. Cases of symptomatic and asymptomatic forms of coronary heart disease in patients with CF were reported [1, 2]; however, no data on the epidemiology of atherosclerosis in patients with CF were published so far. In the past, cardiovascular disease in patients with CF used to be limited to pulmonary heart disease as a consequence of end-stage chronic obstructive pulmonary disease [3]. Although hypertension has not yet been officially recognized as a major problem in this population [4], there are reports indicating that it is found in 20% of patients in adult CF care centers [5]. The project is innovative in nature and necessitates close co-operation between cardiology and basic science units.

scholarly journals Clinical Outcomes of Achromobacter Species in Adult Cystic Fibrosis Patients: A Cohort Study

2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Brett Edwards ◽  
Ranjani Somayaji ◽  
Jasper Greysson-Wong ◽  
Harvey Rabin ◽  
Michael Parkins
Keyword(s):  
Cystic Fibrosis ◽  
Cohort Study ◽  
Clinical Outcomes

Pseudomonas aeruginosa antibody response in cystic fibrosis decreases rapidly following lung transplantation

2020 ◽  
Vol 19 (4) ◽  
pp. 587-594
Author(s):  
Hanna Ferløv Schwensen ◽  
Claus Moser ◽  
Michael Perch ◽  
Tacjana Pressler ◽  
Niels Høiby
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Antibody Response ◽  
Lung Transplantation

Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients

2020 ◽  
Vol 55 (4) ◽  
pp. 959-967 ◽  
Author(s):  
Renan M. Mauch ◽  
Julia Hentschel ◽  
Kasper Aanaes ◽  
Anton Barucha ◽  
Marcos T. Nolasco da Silva ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Antibody Response ◽  
Immune Mediators ◽  
Lower Airways
Sign in / Sign up

Export Citation Format

Share Document